124 related articles for article (PubMed ID: 35045512)
1. [A Case of Esophagogastric Junction Cancer Treated Successfully with Conversion Surgery after Complete Response to Nivolumab Treatment].
Yamazaki K; Taniguchi K; Yamane M; Hattori Y; Koizumi A; Shigehara F; Takashima J; Sugimoto H; Miura F; Matsutani N; Kobayashi H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2121-2123. PubMed ID: 35045512
[TBL] [Abstract][Full Text] [Related]
2. [Successful Treatment of Gastric Cancer with Conversion Surgery after Nivolumab Treatment-A Case Report].
Shiraishi T; Kano M; Sakata H; Murakami K; Toyozumi T; Sekino N; Okada K; Kamata T; Ryuzaki T; Matsubara H
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1614-1616. PubMed ID: 31631152
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Long-Term Survival without Recurrence after Completion of Immunotherapy Due to Response of Third- Line Nivolumab for Liver Metastasis Recurrence of Esophagogastric Junction Cancer].
Ryuzaki T; Sentsui T; Amagai H; Sasagawa S; Kobayashi S; Tsukamoto S; Koide Y; Matsubara H
Gan To Kagaku Ryoho; 2023 Oct; 50(10):1126-1129. PubMed ID: 38035852
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Recurrent Gastric Cancer with Durable Complete Response after Short-Term Nivolumab Therapy].
Yamamichi K; Yamada M; Sumiyama F; Yamamoto N; Hashimoto Y; Satake R; Hatta M; Sakaguchi T; Kotsuka M; Tokuhara K; Inoue K; Sekimoto M
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2052-2054. PubMed ID: 35045490
[TBL] [Abstract][Full Text] [Related]
5. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
[TBL] [Abstract][Full Text] [Related]
6. Pathological Complete Response and Successful Conversion Surgery After Nivolumab Therapy for Stage IV Oesophagogastric Junction Cancer.
Kumamoto T; Tomita T; Hojo Y; Nakamura T; Kurahashi Y; Ishida Y; Miwa H; Hirota S; Shinohara H
In Vivo; 2021; 35(4):2247-2251. PubMed ID: 34182503
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Conversion Surgery for Unresectable Advanced Gastric Cancer of Which Metastatic Site Was Disappear by Chemotherapy but the Primary Site Was Enlarged after Five Years].
Nomura A; Akamaru Y; Nishida K; Mori S; Yasuyama A; Nomura M; Yoshikawa Y; Tamai K; Takiuchi D; Hamakawa T; Tei M; Tsujie M
Gan To Kagaku Ryoho; 2024 Apr; 51(4):473-475. PubMed ID: 38644326
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Recurrent Esophagogastric Junction Cancer Responding to Trastuzumab].
Kobayashi Y; Hirao M; Yamamoto K; Nishikawa K; Maeda S; Uemura M; Miyake M; Hama N; Miyamoto A; Miyazaki M; Ikeda M; Nakamori S; Sekimoto M; Mori K; Mano M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2181-2183. PubMed ID: 28133262
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Long-Term Progress Control of Unresectable Progressive Gastric Cancer with Nivolumab Introduced during Effective Duration of Secondary Treatment].
Eguchi S; Akamaru Y; Wada N; Shimaoka T; Harada S; Ikeshima R; Munakata K; Takiuchi D; Hama N; Ota H; Shibata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2045-2047. PubMed ID: 35045488
[TBL] [Abstract][Full Text] [Related]
10. [Salvage Surgery for Unresectable Advanced Esophagogastric Junction Carcinoma with Multiple Liver Metastases after Successful Second-Line Treatment with Nab-Paclitaxel and Ramucirumab Following a Refractory Response to S-1 plus CDDP Therapy-A Case Report].
Fujita T; Shimizu Y; Dongping F; Yamamoto N; Kobayashi M; Iwabu H; Tsuji A
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1597-1600. PubMed ID: 33268735
[TBL] [Abstract][Full Text] [Related]
11. [Long-Term Response of Nivolumab for Recurrent Lymph Nodes after Surgery for Gastric Cancer-A Case Report].
Katsuyama S; Takeno A; Masuzawa T; Sugimura K; Kihara Y; Haruna K; Shinke G; Ikeshima R; Kawai K; Hiraki M; Katsura Y; Ohmura Y; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1868-1870. PubMed ID: 35045431
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kang YK; Boku N; Satoh T; Ryu MH; Chao Y; Kato K; Chung HC; Chen JS; Muro K; Kang WK; Yeh KH; Yoshikawa T; Oh SC; Bai LY; Tamura T; Lee KW; Hamamoto Y; Kim JG; Chin K; Oh DY; Minashi K; Cho JY; Tsuda M; Chen LT
Lancet; 2017 Dec; 390(10111):2461-2471. PubMed ID: 28993052
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Esophagogastric Junction Adenocarcinoma with Multiple Esophageal Intramural Metastases].
Akamaru Y; Wada N; Wada R; Munakata K; Takiuchi D; Morimoto O; Ota H; Shibata K; Ohashi H
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2126-2128. PubMed ID: 30692306
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Gastric Cancer with Continued Progression-Free Survival Even after Total Gastrectomy and Nivolumab Therapy].
Fujii H; Choda Y; Kubota T; Ishida M; Sato D; Sumitani D; Yoshimitsu M; Nakano K; Harano M; Matsukawa H; Idani H; Shiozaki S; Okajima M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2318-2320. PubMed ID: 32156917
[TBL] [Abstract][Full Text] [Related]
15. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Initially Unresectable Advanced Gastric Cancer Radically Resected by Conversion Surgery after Nivolumab Immunotherapy].
Koizumi N; Kashiwagi S; Ogino S; Kamada Y; Fujiki H; Sakakura C
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1624-1626. PubMed ID: 33268741
[TBL] [Abstract][Full Text] [Related]
17. [A case of unresectable gastric cancer treated with triplet combination chemotherapy with itraconazole and conversion surgery].
Sawasaki M; Shiba T; Hayakawa Y; Kakuno A; Oosaki Y
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(2):153-161. PubMed ID: 35153265
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Unresectable Advanced Gastric Neuroendocrine Cell Carcinoma Treated with Nivolumab].
Yoshioka R; Nagase H; Noguchi K; Hamabe A; Hirota M; Oshima K; Tanida T; Ogino T; Tomimaru Y; Kawase T; Noura S; Imamura H; Iwasawa T; Akagi K; Ando H; Tamura H; Adachi S; Dono K
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1530-1532. PubMed ID: 30382068
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
20. [Long-Term Complete Response by CapeOX plus Nivolumab Chemotherapy for Postoperative Recurrence of Gastric Cancer-A Case Report].
Katsuyama S; Masuzawa T; Sugimura K; Yanagisawa K; Shinke G; Kinoshita M; Ikeshima R; Hiraki M; Ohmura Y; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):326-328. PubMed ID: 38494820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
